Horizon Therapeutics Public Ltd Co

TD ASSET MANAGEMENT INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

10/27/2023

Shares

31,961

Value ($000)

3,698

Weight

0.0%

2020 Q2 - 2023 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	10/27/2023	3,698	0.0%	31,961	9/30/2023
2023 Q2	8/9/2023	3,253	0.0%	31,631	6/30/2023
2023 Q1	5/10/2023	28,535	0.0%	261,450	3/31/2023
2022 Q4	2/7/2023	37,778	0.0%	331,967	12/31/2022
2022 Q3	11/7/2022	1,982	0.0%	31,614	9/30/2022
2022 Q2	8/4/2022	2,475	0.0%	31,033	6/30/2022
2022 Q1	5/10/2022	3,508	0.0%	33,341	3/31/2022
2021 Q4	2/10/2022	3,599	0.0%	33,398	12/31/2021
2021 Q3	11/9/2021	3,822	0.0%	34,887	9/30/2021
2021 Q2	8/11/2021	3,445	0.0%	34,447	6/30/2021
2021 Q1	5/14/2021	3,006	0.0%	32,665	3/31/2021
2020 Q4	2/16/2021	2,453	0.0%	33,535	12/31/2020
2020 Q3	11/10/2020	3,687	0.0%	47,463	9/30/2020
2020 Q2	8/13/2020	2,566	0.0%	46,163	6/30/2020